Atlas Trials

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

Clinical trial NCT00126061 · COMPLETED

Trial details

NCT number
NCT00126061
Sponsor
Solvay Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Atrial FibrillationAtrial Flutter
Start date
2004-10-01
Primary completion
2006-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.